Covered recipient · General Payments record
MARK WINFIELD OWEN
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2023–2024
$1,239.68
- Reported across 49 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,089.83 | 45 |
| Education | $87.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Daiichi Sankyo Inc. | $166.09 | 6 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $141.51 | 9 |
| Bayer HealthCare Pharmaceuticals Inc. | $89.70 | 2 |
| Incyte Corporation | $87.99 | 1 |
| Exelixis Inc. | $75.99 | 2 |
| Regeneron Healthcare Solutions, Inc. | $66.93 | 2 |
| TerSera Therapeutics LLC | $54.74 | 2 |
| GENZYME CORPORATION | $52.65 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $44.03 | 2 |
| GlaxoSmithKline, LLC. | $41.57 | 2 |
| Celgene Corporation | $40.18 | 2 |
| Dendreon Pharmaceuticals LLC | $34.94 | 1 |
| Ipsen Biopharmaceuticals, Inc | $32.53 | 1 |
| Acerta Pharma LLC | $30.30 | 1 |
| EISAI INC. | $30.23 | 1 |
| Deciphera Pharmaceuticals Inc. | $26.78 | 1 |
| EMD Serono, Inc. | $20.66 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $19.88 | 1 |
| Genmab U.S., Inc. | $19.69 | 1 |
| Merck Sharp & Dohme Corporation | $18.87 | 1 |
| SOBI, INC | $18.64 | 1 |
| Astellas Pharma US Inc | $18.35 | 1 |
| Lilly USA, LLC | $16.75 | 1 |
| Janssen Biotech, Inc. | $15.53 | 1 |
| PFIZER INC. | $13.29 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (46)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.